Navigation Links
Linagliptin Demonstrated Significant HbA1c Reduction in Elderly People With Type 2 Diabetes With Inadequate Glycemic Control
Date:8/15/2013

drugs (i.e. metformin and/or sulfonylurea and/or basal insulin). The primary endpoint was change in HbA1c from baseline (7.8 percent for linagliptin versus 7.7 percent for placebo) to week 24. Key results from the study showed that the mean change from baseline in HbA1c  with linagliptin was -0.64 percent (p<0.0001) after 24 weeks, which showed superiority versus placebo, adjusted for a mean 0.04 percent HbA1C increase for placebo . In addition, analysis of a secondary endpoint showed that the placebo-adjusted mean reduction in fasting plasma glucose from baseline with linagliptin was -20.7 mg/dL (-1.15 mmol/L; p<0.0001). 

The percentage of people with any adverse event was the same in both treatment groups (75.9 percent). Common adverse events included hypoglycemia (low blood glucose; 22.8 percent and 16.5 percent for linagliptin and placebo, respectively), nasopharyngitis (common cold; 10.5 percent in the linagliptin arm and 8.9 percent on placebo), diarrhea (5.6 percent in the linagliptin arm and 2.5 percent on placebo), hyperglycemia (high blood glucose; 5.6 percent and 10.1 percent for linagliptin and placebo, respectively), back pain (7 percent for linagliptin), fall (4.3 percent and 2.5 percent for linagliptin and placebo, respectively) and urinary tract infection (4.3 percent in the linagliptin arm and 6.3 percent on placebo). One patient per group had a drug-related adverse event leading to discontinuation of the study.  Investigator-defined hypoglycemia occurred in 24.1 percent of the linagliptin group and 16.5 percent of the placebo group.

"Elderly people with type 2 diabetes have different challenges managing their blood sugar levels," said Christophe Arbet-Engels, MD, PhD, vice president, metabolic clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "This study shows linagliptin may help to reduce blood sugar levels in elderly people with inadequat
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
3. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
4. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
7. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
8. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
9. Groundbreaking UK Study Confirms Significant Reduction in Hospital Superbug Pathogens with TRU-D SmartUVC Disinfection Robot
10. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
11. Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Seventy-one percent of Americans believe the ... a serious public health and safety issue in ... survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse problem ... this very serious health situation facing our country," Rex ...
(Date:8/21/2014)... 2014  Henry Schein, Inc. (NASDAQ: HSIC ), ... to office-based dental, animal health and medical practitioners, announced today ... September: , September 4, 2014 – Baird 2014 ... 12:50 p.m. ET , September 8, 2014 – ... York , NY at 1:25 p.m. ET ...
(Date:8/21/2014)... , Aug. 21, 2014 CVS Caremark Corporation ... results, applicable Reference Yields and consideration payable in connection with ... on August 7, 2014 for (1) any and all of ... Notes") and (2) up to a maximum amount of its ... and 5.750% Senior Notes due 2017 (collectively, the "Maximum Tender ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3Henry Schein To Present At Two Investor Conferences In September 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
(Date:8/21/2014)... 2014 UWDress.com, a well-known wedding dress manufacturer, ... to its online store. In addition to this, all ... to 72 percent off) at the moment. The special offer ... , UWDress.com’s kind online workers have updated its online category ... that the company’s website is a one stop place where ...
(Date:8/21/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW) , Browse 138 market ... and in-depth TOC on “Proteomics Market by Technology ...
(Date:8/21/2014)... August 22, 2014 Top10BestSEOHosting.com has ... announces that iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one ... 2014. , The manager of Top10BestSEOHosting.com states, ... hosting supplier. Actually, these companies have outperformed their ... customer support. People can get the best web ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 An increasing ... a taxpayer that their federal tax payment is being ... appears to come from the IRS, “tax@irs.gov”, it’s actually ... provide personal and financial information. , While similar scams ... an uptick in phishing activity is occurring right now. ...
(Date:8/21/2014)... advanced laryngeal cancer appear to have better survival ... chemoradiation. , Author: Uchechukwu C. Megwalu, M.D., M.P.H., ... Sinai, New York, and colleagues. , Background: Approximately ... diagnosed each year and squamous cell carcinoma accounts ... to 1991, total surgical removal of the larynx ...
Breaking Medicine News(10 mins):Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2
... that altruistic nature where high in our ancestors, they ... food and also had the habit of exchanging gifts ... origin of holiday giving. Michael Gurven, University of California ... in humans and a core feature of reciprocity is ...
... The collaboration between Apollo Hospitals and the Stanford ... a launch of a first-ever international programme for ... one-year full time programme would be conducted at ... passed Intermediate or an equivalent examination are eligible ...
... University of Navarre has reported in her thesis that ... She tested 24 compounds isolated from the derivatives and ... tested in invitro cell cultures. Initial studies have found ... feels that still a lot has to be done ...
... from University of Illinois have found that eating disorders ... childhood. Eating disorder develops in women who had experienced// ... life. The researchers have published the results of their ... ,The Research team conducted the survey in 608 students ...
... a Swiss study, which found that the instrument can ... ,Swiss researchers have discovered that playing the Aboriginal instrument ... sleep apnoea, reports the British Medical Journal. ... during sleep, and results in the sufferer gasping for ...
... which have made it mandatory for all adults over 40 years ... of the fact that the family may have no history with ... history of such problems, the tests will have to be undergone ... six stroke and heart societies have given their support for the ...
Cached Medicine News:
... to complement the active lifestyle, ... contemporary--and comfortable--eyewear for men, women ... offers a wide variety of ... with a young, relaxed attitude, ...
... Whisper NG Erbium YAG Extended Ablation laser ... true laser peel with outstanding results and no ... a proprietary fluence level with an extra long ... skin. Peeling is spread over 3-5 days, ...
... Biomedics EP is the first and only ... are just beginning to have difficulty reading ... ,While everyone wants to enjoy the best ... bifocals or reading glasses. Fortunately, Biomedics EPs ...
... The table-mounted hip ... hands-free exposure for total ... to accommodate individual surgeon ... of any size. Hand-held ...
Medicine Products: